«

»

Nov 15

AHA update: Extended Apixaban Fails to Beat Enoxaparin for VTE

Medically ill patients at risk for venous thromboembolism did not obtain significant benefit from month-long treatment with apixaban  ( an anti coagulant) when compared with two weeks of treatment with the enoxaparin ( LMW Heparin), said Samuel Z. Goldhaber, MD, from Brigham & Women’s Hospital and Harvard Medical School in Boston.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>